NDC codes

FDA NDC Directory
Product NDC (as listed)82584-003Labeler and product segments. Claims need a package NDC.
Product NDC at billing width82584-0003Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
82584-003-308258400033030 POUCH in 1 CARTON (82584-003-30) / .2 mL in 1 POUCHMarketed from Jul 14, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Iyuzeh
Generic name (nonproprietary)
latanoprost ophthalmic solution 0.005%
Active ingredients
Latanoprost — 50 ug/mL
Dosage form
Solution/ drops
Route
Ophthalmic
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 216472
Marketing start
Listing expires
Identifiers
Product ID 82584-003_1e77daf5-a752-172c-e063-6394a90a8a4dSPL ID 1e77daf5-a752-172c-e063-6394a90a8a4dSPL set ID 192fc081-cc38-4e83-b779-9592e060b915RxCUI 314072, 2642284UNII 6Z5B6HVF6O

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N482584000330 followed by a unit qualifier and the quantity

Package 82584-0003-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

IYUZEH ™ (latanoprost ophthalmic solution) 0.005% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. IYUZEH is a prostaglandin F2α analogue indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in